MA45375A - Composés hétérocycliques utilisés en tant qu'agents antibacteriens - Google Patents
Composés hétérocycliques utilisés en tant qu'agents antibacteriensInfo
- Publication number
- MA45375A MA45375A MA045375A MA45375A MA45375A MA 45375 A MA45375 A MA 45375A MA 045375 A MA045375 A MA 045375A MA 45375 A MA45375 A MA 45375A MA 45375 A MA45375 A MA 45375A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds used
- antibacterial agents
- heterocyclic compounds
- heterocyclic
- antibacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16174722 | 2016-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45375A true MA45375A (fr) | 2019-04-24 |
Family
ID=56132839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045375A MA45375A (fr) | 2016-06-16 | 2017-06-15 | Composés hétérocycliques utilisés en tant qu'agents antibacteriens |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200308169A1 (fr) |
| EP (1) | EP3472152A1 (fr) |
| JP (1) | JP2019518050A (fr) |
| KR (1) | KR20190018681A (fr) |
| CN (1) | CN109415349A (fr) |
| AU (1) | AU2017286370B2 (fr) |
| BR (1) | BR112018075939A2 (fr) |
| CA (1) | CA3025727A1 (fr) |
| EA (1) | EA201990044A1 (fr) |
| MA (1) | MA45375A (fr) |
| MX (1) | MX2018015657A (fr) |
| WO (1) | WO2017216283A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201890201A1 (ru) | 2015-07-02 | 2018-06-29 | Янссен Сайенсиз Айрлэнд Юси | Антибактериальные соединения |
| WO2017049321A1 (fr) | 2015-09-17 | 2017-03-23 | Miller Marvin J | Composés hétérocycliques contenant de la benzylamine et compositions utiles contre une infection mycobactérienne |
| AU2017286368B2 (en) | 2016-06-16 | 2021-02-25 | Janssen Sciences Ireland Unlimited Company | Heterocyclic compounds as antibacterials |
| EA201991997A1 (ru) | 2017-03-01 | 2020-01-22 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Комбинированная терапия |
| MX2022002878A (es) | 2019-09-10 | 2022-05-06 | Shionogi & Co | Compuestos 5,6-heteroaromaticos que contienen bencilaminas utiles contra la infeccion por micobacterias. |
| JP2022548247A (ja) * | 2019-09-13 | 2022-11-17 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | 抗菌化合物 |
| JP2022551823A (ja) | 2019-09-30 | 2022-12-14 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | 抗菌化合物 |
| BR112022005068A2 (pt) | 2019-09-30 | 2022-09-06 | Janssen Sciences Ireland Unlimited Co | Compostos antibacterianos de 4-quinolinona |
| AU2022237769A1 (en) | 2021-03-16 | 2023-11-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| AU2022236404A1 (en) | 2021-03-17 | 2023-11-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| CA3211592A1 (fr) | 2021-03-17 | 2022-09-22 | Jerome Emile Georges Guillemont | Composes antibacteriens |
| WO2022214520A1 (fr) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| WO2022214519A1 (fr) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| AU2022377203A1 (en) | 2021-10-28 | 2024-06-13 | Janssen Sciences Ireland Unlimited Company | Imidazopyridine amides and related compounds for use in the treatment of bacterial infections |
| WO2024089170A1 (fr) | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| WO2024223859A1 (fr) | 2023-04-26 | 2024-10-31 | Janssen Pharmaceutica Nv | Composés antibactériens |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1527050T3 (da) | 2002-07-25 | 2010-07-19 | Janssen Pharmaceutica Nv | Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer |
| US9309238B2 (en) * | 2009-11-05 | 2016-04-12 | University Of Notre Dame Du Lac | Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same |
| EP2547678B1 (fr) * | 2010-03-18 | 2016-03-16 | Institut Pasteur Korea | Composés anti-infectieux |
| WO2013033167A1 (fr) | 2011-09-01 | 2013-03-07 | Irm Llc | Composés et compositions en tant qu'inhibiteurs de kinase c-kit |
| US9199981B2 (en) | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
| CN104718213B (zh) * | 2012-07-18 | 2018-02-27 | 圣母大学 | 5,5‑杂芳族抗感染化合物 |
| CN109575018A (zh) * | 2013-08-02 | 2019-04-05 | 韩国巴斯德研究所 | 一种抗感染化合物 |
| CN105524058B (zh) * | 2014-10-21 | 2018-03-27 | 广州艾格生物科技有限公司 | 吡唑并[1,5‑a]吡啶类化合物及其应用 |
-
2017
- 2017-06-15 CN CN201780037163.9A patent/CN109415349A/zh active Pending
- 2017-06-15 AU AU2017286370A patent/AU2017286370B2/en not_active Expired - Fee Related
- 2017-06-15 US US16/309,772 patent/US20200308169A1/en not_active Abandoned
- 2017-06-15 MA MA045375A patent/MA45375A/fr unknown
- 2017-06-15 WO PCT/EP2017/064654 patent/WO2017216283A1/fr unknown
- 2017-06-15 CA CA3025727A patent/CA3025727A1/fr not_active Abandoned
- 2017-06-15 KR KR1020197000961A patent/KR20190018681A/ko not_active Application Discontinuation
- 2017-06-15 EP EP17729495.6A patent/EP3472152A1/fr not_active Withdrawn
- 2017-06-15 JP JP2018565691A patent/JP2019518050A/ja active Pending
- 2017-06-15 EA EA201990044A patent/EA201990044A1/ru unknown
- 2017-06-15 MX MX2018015657A patent/MX2018015657A/es unknown
- 2017-06-15 BR BR112018075939-2A patent/BR112018075939A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190018681A (ko) | 2019-02-25 |
| AU2017286370B2 (en) | 2021-09-09 |
| CA3025727A1 (fr) | 2017-12-21 |
| WO2017216283A1 (fr) | 2017-12-21 |
| EP3472152A1 (fr) | 2019-04-24 |
| MX2018015657A (es) | 2019-03-14 |
| BR112018075939A2 (pt) | 2019-04-09 |
| AU2017286370A1 (en) | 2018-12-06 |
| EA201990044A1 (ru) | 2019-05-31 |
| US20200308169A1 (en) | 2020-10-01 |
| JP2019518050A (ja) | 2019-06-27 |
| CN109415349A (zh) | 2019-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45375A (fr) | Composés hétérocycliques utilisés en tant qu'agents antibacteriens | |
| MA45377A (fr) | Composés hétérocycliques en tant qu'agents antibacteriens | |
| MA47099A (fr) | Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs | |
| MA43169A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de pi3k-gamma | |
| MA51438A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1 | |
| MA55194A (fr) | Composés hétérocycliques en tant qu'immunomodulateurs | |
| MA52486A (fr) | Pyridazinones utilisés en tant qu'inhibiteurs de parp7 | |
| MA49888A (fr) | Composés macrocycliques utilisés en tant qu'inhibiteurs de kinase ros1 | |
| MA47120A (fr) | Dérivés pyridine utilisés en tant qu'immunomodulateurs | |
| MA51878A (fr) | Composés d'aminothiazole en tant qu'inhibiteurs de c-kit | |
| MA42990A (fr) | Composés utiles en tant qu'immunomodulateurs | |
| MA47013A (fr) | Composés benzolactames utilisés en tant qu'inhibiteurs de protéine kinase | |
| MA53150A (fr) | Composés de benzimidazole en tant qu'inhibiteurs de c-kit | |
| MA54076A (fr) | 2-amino-n-hétéroaryl-nicotinamides utilisés en tant qu'inhibiteurs de nav1.8 | |
| MA54169A (fr) | Tolyles substitués utilisés en tant que fongicides | |
| MA46091A (fr) | Composés biaryles utiles en tant qu'immunomodulateurs | |
| MA49566A (fr) | Carboxamides utilisés en tant qu'inhibiteurs des canaux sodiques | |
| MA51846A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinases | |
| MA42919A (fr) | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx | |
| MA41551A (fr) | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 | |
| MA46045A (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| MA42918A (fr) | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx | |
| MA45669A (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| MA40587A (fr) | Composés d'aminopyrimidinyle en tant qu'inhibiteurs de jak | |
| MA44860A (fr) | Composés hétérocycliques utilisés comme immunomodulateurs |